Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/295"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"evidence_1195"
|
| rdf:type | |
| ?:Evidence_enzyme_system | |
| ?:Evidence_numb_subjects | |
| ?:Evidence_object_dose | |
| ?:Evidence_precip_dose | |
| ?:Evidence_type | |
| ?:Evidence_value | |
| ?:content |
"Route of administration: oral
study duration: This was a non-random, fixed order, study. Participants received a simultaneous dose of .05mg/kg of IV midazolam and 4mg of oral midazolam to collect baseline data. 24 hours later 500mg bid of oral clarithromycin was given to participants for 7 days. On the last day .05mg/kg of IV midazolam and 4mg of oral midazolam was administered after the last dose of clarithromycine
population: 16 : 8 male, 8 female
ages: 30-38
AUC_i/AUC (radiolabeled oral): 336/48 = 7"
|
| dc:creator | |
| dc:date |
"10/30/2007 07:28:31"
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ clarithromycin_increases_auc_midazolam, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1195 }